Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 42

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 42
---
 audited financial statements should be included in our annual report; |

| • |     | monitoring our internal control over financial reporting, disclosure controls and procedures and code of business conduct and ethics; |

| • |     | overseeing our internal audit function; |

| • |     | discussing our major financial risk exposures and risks relating to data privacy and cybersecurity, and our risk management policies; |

| • |     | establishing policies regarding hiring employees from the registered public accounting firm and procedures for the receipt, retention and treatment of accounting related complaints and concerns; |

| • |     | meeting independently with our internal auditing staff, registered public accounting firm and management; |

| • |     | review the results of our efforts to monitor compliance with our programs and policies designed to promote adherence to applicable laws and regulations; |

| • |     | review our investment portfolio and investment policy on a periodic basis; |

| • |     | reviewing and approving or ratifying any related person transactions; and |

| • |     | preparing the audit committee report required by SEC rules, which is included on page 37 of this Proxy Statement. |

Compensation & People Committee The members of our compensation & people committee are Ms. Foster, Ms. Owen and Ms. Smith. Ms. Smith is the chair of the compensation & people committee. Our compensation & people committee assists our board of directors in the discharge of its responsibilities relating to the compensation of our executive officers and directors. The compensation & people committee met seven times during fiscal year 2024, including telephonic and virtual meetings. The compensation & people committee’s responsibilities include:

| • |     | reviewing and approving corporate goals and objectives relevant to chief executive officer compensation; |

| • |     | making recommendations to our board of directors with respect to the compensation of our chief executive officer, and reviewing and approving the compensation of our other executive officers; |

| • |     | overseeing an evaluation of our senior executives; |

| • |     | overseeing and administering our cash and equity incentive plans; |

29

| • |     | overseeing our policies and practices regarding the timing of equity grants in relation to the release of material nonpublic information; |

| • |     | reviewing and making recommendations to our board of directors with respect to director compensation; |

| • |     | reviewing and discussing with management our “Compensation Discussion and Analysis,” which is included on page 40 of this Proxy Statement; |

| • |     | preparing the compensation & people committee report required by SEC rules, which is included